학술논문

Stemness signature and targeted therapeutic drugs identification for Triple Negative Breast Cancer.
Document Type
Article
Source
Scientific Data; 11/20/2023, Vol. 10 Issue 1, p1-14, 14p
Subject
TRIPLE-negative breast cancer
TARGETED drug delivery
HER2 gene
MOLECULES
GENE expression
CANCER genes
PROGRAMMED cell death 1 receptors
Language
ISSN
20524463
Abstract
Copyright of Scientific Data is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)